Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis (MS) - Relapsing-remitting”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00461396
What this trial is testing

Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Bayer 104
Not applicableUnknownNCT04260711
What this trial is testing

Discontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS).

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive
Amsterdam UMC, location VUmc 130
Not applicableStudy completedNCT06987994
What this trial is testing

The Effect of Virtual Reality on Fatigue and Functional Capacity in Patients With MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingVirtual Reality
Istinye University 30
Early research (Phase 1)Study completedNCT02506751
What this trial is testing

Open-label Study of Liothyronine in MS

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary Progressive
Johns Hopkins University 20
Testing effectiveness (Phase 2)Study completedNCT01185821
What this trial is testing

Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 185
Testing effectiveness (Phase 2)Study completedNCT00382629
What this trial is testing

BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Bayhill Therapeutics 252
Not applicableStudy completedNCT07346924
What this trial is testing

Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) Relapsing Remitting
Cairo University 60
Not applicableStudy completedNCT05663853
What this trial is testing

An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive
LAPIX Therapeutics Inc. 137
Testing effectiveness (Phase 2)Ended earlyNCT00095329
What this trial is testing

Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
National Institute of Allergy and Infectious Diseases (NIAID) 14
Not applicableEnded earlyNCT02266121
What this trial is testing

Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple SclerosisSecondary-progressive Multiple SclerosisCognitive Deficits+1 more
University Hospital of Mont-Godinne 100
Large-scale testing (Phase 3)Study completedNCT01307332
What this trial is testing

Advanced MRI Measures of Repair in Alemtuzumab Treated Patients

Who this might be right for
Relapsing Remitting Multiple Sclerosis
University of British Columbia 27
Large-scale testing (Phase 3)Study completedNCT00835770
What this trial is testing

BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 1,736
Not applicableEnded earlyNCT01905527
What this trial is testing

Adherence Trial With MS LifeLines ® Services

Who this might be right for
Multiple SclerosisRelapsing-Remitting
EMD Serono 306
Post-approval studies (Phase 4)Study completedNCT02461069
What this trial is testing

Investigation of the Effect of Dimethyl Fumarate on T Cells in Patients With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University Hospital Muenster 67
Large-scale testing (Phase 3)Study completedNCT04788615
What this trial is testing

Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 185
Testing effectiveness (Phase 2)UnknownNCT01466114
What this trial is testing

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

Who this might be right for
Relapsing-remitting Multiple SclerosisSecondary-progressive Multiple SclerosisPrimary-progressive Multiple Sclerosis
University of California, Los Angeles 64
Testing effectiveness (Phase 2)Study completedNCT00203099
What this trial is testing

Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine

Who this might be right for
Relapse Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 18
Testing effectiveness (Phase 2)UnknownNCT00151801
What this trial is testing

Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients

Who this might be right for
Multiple Sclerosis
S. Andrea Hospital 200
Not applicableStudy completedNCT00704834
What this trial is testing

Gene Expression Profiles in Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
University of California, Davis 46
Not applicableUnknownNCT03787446
What this trial is testing

PET Study in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of British Columbia 9
Next Page